4-AcO-McPT
| Clinical data | |
|---|---|
| Other names | 4-AcO-MCPT; 4-Acetoxy-N-methyl-N-cyclopropyltryptamine |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C16H20N2O2 |
| Molar mass | 272.348 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-AcO-McPT, also known as 4-acetoxy-N-methyl-N-cyclopropyltryptamine, is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to 4-AcO-DMT (psilacetin). It is the acetate ester of 4-HO-McPT. The drug is assumed to act on serotonin receptors. It was encountered as a novel designer drug in Slovenia in October 2023. 4-AcO-McPT has not otherwise been encountered, for instance on specialized drug forums or being sold by vendors, as of December 2023.